Chimera Investment - CIM Stock Forecast, Price & News

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Chimera Investment in the last year. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" CIM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CIM, but not buy additional shares or sell existing shares.
View CIM analyst ratings or view top-rated stocks.

3 equities research analysts have issued 12-month price objectives for Chimera Investment's stock. Their CIM share price forecasts range from $6.50 to $9.00. On average, they expect the company's stock price to reach $7.50 in the next twelve months. This suggests a possible upside of 38.1% from the stock's current price.
View analysts price targets for CIM or view top-rated stocks among Wall Street analysts.

Chimera Investment's stock was trading at $5.50 at the beginning of 2023. Since then, CIM stock has decreased by 1.3% and is now trading at $5.43.
View the best growth stocks for 2023 here.

Chimera Investment saw a increase in short interest during the month of February. As of February 28th, there was short interest totaling 9,200,000 shares, an increase of 5.5% from the February 13th total of 8,720,000 shares. Based on an average daily trading volume, of 1,930,000 shares, the days-to-cover ratio is currently 4.8 days. Currently, 4.0% of the shares of the company are sold short.
View Chimera Investment's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023.
View our CIM earnings forecast.

Chimera Investment Co. (NYSE:CIM) issued its earnings results on Wednesday, February, 15th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts' consensus estimates of $0.24 by $0.13. The real estate investment trust earned $187.29 million during the quarter, compared to analyst estimates of $97.90 million. Chimera Investment had a negative net margin of 66.36% and a positive trailing twelve-month return on equity of 11.35%. During the same period in the previous year, the firm earned $0.46 earnings per share.

Chimera Investment announced a quarterly dividend on Thursday, February 2nd. Shareholders of record on Friday, March 31st will be paid a dividend of $0.23 per share on Thursday, April 27th. This represents a $0.92 dividend on an annualized basis and a yield of 16.94%. The ex-dividend date of this dividend is Thursday, March 30th.
Read our dividend analysis for CIM.

ETFs with the largest weight of Chimera Investment (NYSE:CIM) stock in their portfolio include VanEck Mortgage REIT Income ETF (MORT), Invesco KBW High Dividend Yield Financial ETF (KBWD), iShares Mortgage Real Estate ETF (REM), WisdomTree Alternative Income Fund (HYIN), Hoya Capital High Dividend Yield ETF (RIET), Global X SuperDividend ETF (SDIV), GraniteShares HIPS US High Income ETF (HIPS) and Hoya Capital Housing ETF (HOMZ).

Chimera Investment (NYSE:CIM) pays an annual dividend of $0.92 per share and currently has a dividend yield of 17.33%. CIM has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for CIM.

Chimera Investment updated its fourth quarter earnings guidance on Thursday, February, 2nd. The company provided earnings per share (EPS) guidance of $0.16 for the period, compared to the consensus EPS estimate of $0.24.

3 employees have rated Chimera Investment Chief Executive Officer Matthew Lambiase on Glassdoor.com. Matthew Lambiase has an approval rating of 100% among the company's employees. This puts Matthew Lambiase in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Chimera Investment investors own include New Residential Investment (NRZ), Annaly Capital Management (NLY), Marathon Oil (MRO), AGNC Investment (AGNC), Energy Transfer (ET), AT&T (T), ARMOUR Residential REIT (ARR), New York Mortgage Trust (NYMT), Enterprise Products Partners (EPD) and NGL Energy Partners (NGL).

Chimera Investment trades on the New York Stock Exchange (NYSE) under the ticker symbol "CIM."

Chimera Investment's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Geode Capital Management LLC (1.86%), Leeward Investments LLC MA (1.35%), Charles Schwab Investment Management Inc. (0.92%), Norges Bank (0.82%), Morgan Stanley (0.59%) and Barclays PLC (0.56%).
View institutional ownership trends.

Shares of CIM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CIM stock can currently be purchased for approximately $5.43.

Chimera Investment (NYSE:CIM) has a market capitalization of $1.26 billion and generates $773.12 million in revenue each year. The real estate investment trust earns $-513,070,000.00 in net income (profit) each year or ($2.49) on an earnings per share basis.

Chimera Investment's mailing address is 520 MADISON AVENUE 32ND FLOOR, NEW YORK NY, 10022. The official website for the company is www.chimerareit.com. The real estate investment trust can be reached via phone at (888) 895-6557, via email at investor@chimerareit.com, or via fax at 212-696-9809.